This site is intended for health professionals only

UKCPA position statement on AF management


UKCPA position statement

July 2011

Article continues below this sponsored advert
Cogora InRead Image
Join us at a one-day virtual cardiology event that will allow you to explore the latest advances in cardiovascular care. With the help of an advisory board of cardiology specialists we have put together an agenda tailored to multi-disciplinary teams - each talk is presented by an expert, or panel, who will share knowledge and case studies of relevance

Atrial fibrillation is currently the focus of a national quality, innovation, productivity and prevention programme in the UK. 

The programme aims to improve quality outcomes for patients with atrial fibrillation (AF) and reduce health and social care costs by reducing the risk of stroke through service developments to improve detection, diagnosis and management in primary care. This includes promoting the importance of stroke risk assessment for all patients with AF and the initiation of oral anticoagulant therapy in appropriate patients. 

At least two new oral anticoagulants (NOACs) are expected to be licensed for stroke prevention in AF during 2011/12

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine